80
Participants
Start Date
August 31, 2011
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
TC-5214
Tablet oral bid days 1 to 7
TC-5214
Tablet oral bid days 8 to 14
Research Site, Overland Park
Research Site, Willingboro
Research Site, Berlin
Research Site, London
Lead Sponsor
AstraZeneca
INDUSTRY